• English
  • Français
  • Español
  • Facebook
  • RSS
  • Twitter

Therapeutics Initiative

Independent Healthcare Evidence

  • TI
  • About Us
    • Oversight Committee
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
    • Questions & Answers
  • Therapeutics Letter
  • Our Evidence Reviews
  • Portrait
  • Continuing Education
  • Contact Us
  • Subscribe
Home > Education > [Sep 16] TI Best Evidence Webinar: “We” Should Really Stop that PPI, eh?

[Sep 16] TI Best Evidence Webinar: “We” Should Really Stop that PPI, eh?

July 31, 2020 Education, Podcasts & Videos Leave a Comment

Download
Share

TI Best Evidence Webinar

“We” Should Really Stop that PPI, eh?

PRESENTERS: Dr. Carolyn Bubbar & Hafeez Dossa

DATE: Wednesday, September 16th 2020

TIME: 12:00 noon – 13:15 Pacific Daylight Time PDT [UTC -7 convert to your local time]

CME CREDITS: MainPro+/MOC Section 1 credits: 1.0. You must register, attend the webinar and complete the evaluation in order to receive your certificate.


This event has already taken place. Scroll down to view a video recording of the event.


Learning objectives: by the end of this session, participants should be able to learn how to overcome barriers, such as time to:

  1. Review a patient’s PPI use
  2. Communicate with prescribers a recommendation to continue, adjust, or stop medication
  3. Empower care staff to monitor and adjust the plan

Speaker Biographies:

Dr Carolyn Bubbar completed her undergraduate degree in Pharmacy at the University of Saskatchewan and then a hospital pharmacy residency with the Saskatoon Health Region in 2000. She worked as a hospital pharmacist in various clinical areas for several years before moving to Toronto to complete their post-graduate PharmD degree in 2006.  Since then she has moved across the country with her husband and 2 kids and made a home in the White Rock area. She works at Peace Arch Hospital in White Rock as a Clinical Pharmacy Specialist in Geriatrics focused primarily on the inpatient ACE Unit (Acute Care for Elderly). She also attends weekly care conferences in the Long-Term Care Facility associated with the hospital.  She has a clinical teaching role precepting both UBC pharmacy students and hospital pharmacy residents.

Hafeez Dossa is a Pharmacy Manager with Care Rx in Nanaimo, a pharmacy that services long term care and assisted living facilities across Vancouver Island. He completed his education first at SFU, where he received a B.Sc in Biomedical Physiology, and followed this with a B.Sc in Pharmacy at UBC. After traveling to Australia and New Zealand following the completion of his pharmacy degree (Skydiving over Abel Tasman National Park and Heli-Hiking the Franz Jozef Glacier were the highlights), he began his role with Care Rx.
In this practice setting, Hafeez has found many opportunities to optimize medication management, as polypharmacy is essentially a given for patients upon admission (it’s rare to see a patient taking less than 8 medications when admitted). Using his passion for reducing the use of unnecessary medications, Hafeez has, though meaningful medication reviews and care conferences, achieved significant reductions in various drug classes including antipsychotics, antihypertensives, dementia medications, and most recently, proton pump inhibitors.


https://www.ti.ubc.ca/wordpress/wp-content/uploads/2020/09/PPI_16Sep2020.mp4

RESOURCES:

Choosing Wisely Canada

  • Bye Bye PPI Toolkit (https://choosingwiselycanada.org/perspective/ppi-toolkit/)
  • Pharmacist recommendations, including “Don’t renew long-term proton pump inhibitor (PPI) therapy for gastrointestinal symptoms without an attempt to stop or reduce (taper) therapy at least once per year for most patients.” (https://choosingwiselycanada.org/pharmacist/)
  • Gastroenterology recommendations “Don’t maintain long term Proton Pump Inhibitor (PPI) therapy for gastrointestinal symptoms without an attempt to stop/reduce PPI at least once per year in most patients.”

Canadian Deprescribing Network (CaDeN)

  • Do I still need this medication? PPI Handout for patients (http://www.criugm.qc.ca/fichier/pdf/PPI-EN-Men.pdf)

Deprescrbing.org

  • PPI Deprescribing Algorithm (https://deprescribing.org/wp-content/uploads/2018/08/ppi-deprescribing-algorithm_2018_En.pdf)
    • Corresponding guideline https://www.cfp.ca/content/63/5/354

More information about PPIs in Therapeutics Letters:

  • [99] Comparative effectiveness of proton pump inhibitors
  • [111] Deprescribing Proton Pump Inhibitors
  • [118] Trends in utilization of proton pump inhibitors in British Columbia
  • [126] Serious harms with long-term PPI use in older adults

Sample PPI Deprescribing Letter (Courtesy of Hafeez Dossa)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

 

  • About Us
    • Oversight Committee
    • Questions & Answers
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
  • Portrait
    • Frequently Asked Questions
    • Portrait Contact
  • Therapeutics Letter
  • Our Evidence Reviews
  • Get Involved
  • Continuing Education
    • Best Evidence
  • Contact Us
  • Terms & Policies
    • Legal Information & Terms of Use
    • Privacy Policy
    • Acceptable Use Policy

Categories

  • News (123)
  • Therapeutics Letter (133)
  • Portrait (1)
  • Drug Assessments (39)
  • PharmacoEpidemiology (75)
  • Podcasts & Videos (50)

Recent Seminars

Dr. Jessica Otte: We Need To Talk About Tramadol

Share

[Feb 10] Therapeutics Initiative Best Evidence Webinar: Sex and Post-SSRI Evidence-based Medicine Dysfunction

Register
Share

[Mar 10] Therapeutics Initiative Virtual Workshop – Using Evidence in Shared Decision Making: A Case-based, Critical Appraisal Approach for Busy Clinicians

Register
Share

Therapeutics Initiative

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. Read more Donate

Contact

2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3
Contact us
Office: +1 604-822-0700
Fax: +1 604-822-0701

UBC logoISDB logo

Subscribe

Subscribe to receive email notifications from the TI about the Therapeutics Letter, upcoming educational events, personal prescribing portraits and other news and recent publications. SUBSCRIBE

© 1994 - 2021 Therapeutics Initiative · Terms & Policies · TM